BBC.US Virtus LifeSci Biotech Clinical Trials ETF

- USD
No recent price
Total assets
31.3M
Expense ratio
0.75%
Dividend yield
1.49%
1-year return
+43.64%
Holdings
127
Since
2014

Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.

What does BBC.US invest in?

  • Mostly US stocks (86.2%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (93.5%)
  • Top 3 holdings: 7.0% of the fund

Asset allocation

  • US stocks 86.2%
  • Non-US stocks 9.8%
  • Cash 0.2%

Top holdings

All holdings, sectors and regions

Virtus LifeSci Biotech Clinical Trials ETF performance

Sharpe ratio 0.94
This year
+17.87%
1 year
+43.64%
3 years
+40.35%
5 years
+0.51%

Volatility 33.0% over 1 year and 36.6% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

BBC.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About Virtus LifeSci Biotech Clinical Trials ETF

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Full fund profile